A Study of Chemoradiation in Combination With Tislelizumab as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
Condition:   Esophageal Squamous Cell Carcinoma Interventions:   Radiation: Intensity-modulated radiotherapy (IMRT);   Drug: Tislelizumab;   Drug: Cisplatin;   Drug: Nab paclitaxel Sponsor:   Renmin Hospital of Wuhan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials

Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma
Condition:   Stage IVA Nasopharyngeal Carcinoma Intervention:   Radiation: Intensity modulated radiation therapy (IMRT) combined with chemotherapy Sponsor:   Jiangsu Cancer Institute & Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials